Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100)
Clinical trial NCT02718417 · TERMINATED
Trial details
- NCT number
- NCT02718417
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-19
- Primary completion
- 2018-09-07
- Enrollment
- 998
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.